ALLR 8-K 2026-11-02

Allarity Therapeutics, Inc. (ALLR) 8-K dated 2026-11-02 — accession 0001213900-26-114682.

Allarity Therapeutics, Inc. (ALLR) is a biotechnology company listed on US.

Allarity Therapeutics, Inc. filed a 8-K on 2026-11-02. Accession 0001213900-26-114682.

This 8-K covers: Material agreement (Item 1.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ALLR revenue for 2025-12-31 was $320.0K. Net income was -$11.2M. ALLR currently screens at market cap $15.1M.

Not investment advice. The ALLR SEC hub lists recent forms. The stock page is the research view.